Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Feline Vaccines Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market for feline vaccines has experienced substantial growth in recent years. It is projected to increase from $1.77 billion in 2025 to $1.91 billion in 2026, at a compound annual growth rate (CAGR) of 7.6%. The expansion observed in the past can be attributed to factors such as growing pet adoption rates, a heightened awareness of feline health, the rising prevalence of infectious diseases, an expanding veterinary care infrastructure, and increased compliance with routine vaccinations.
The feline vaccines market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $2.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. The expansion throughout the forecast period stems from factors such as a heightened demand for sophisticated feline immunization, a stronger emphasis on preventative veterinary care, the increasing uptake of combination vaccines, greater investment in biotechnology for companion animals, and a growing focus on vaccination early in a cat’s life. Key trends anticipated during this period encompass vaccine innovations propelled by technology, progress in recombinant and DNA vaccine platforms, improvements in adjuvant and antigen delivery mechanisms, increased research and development efforts in feline immunology, and novel approaches in needle-free and intranasal vaccination techniques.
Download A Free Sample Report For Comprehensive Market Insights:
Feline Vaccines Market Opportunity Drivers: What Is Creating New Revenue Potential?
The expanding pet cat population is anticipated to propel the growth of the feline vaccines market moving forward. This refers to the increasing number of domesticated cats kept by households for companionship, emotional support, and recreational purposes. The rise in the pet cat demographic is attributed to higher pet adoption rates, alongside a growing recognition of the mental and emotional advantages linked to pet ownership. Feline vaccines play a vital role in reducing the prevalence of infectious diseases in cats by bestowing immunity against conditions like feline leukemia virus (FeLV), feline panleukopenia, herpesvirus, and calicivirus, thereby extending their lifespan and improving overall feline health. For instance, in June 2025, as reported by the American Pet Products Association (APPA), a US-based trade association, cat ownership experienced a 23 percent increase in 2024, with the number of households rising from 40 million in 2023 to 49 million in 2024. Consequently, the increasing pet cat population is a primary driver for the growth of the feline vaccines market.
Feline Vaccines Market Segmentation And Category Breakdown
The feline vaccines market covered in this report is segmented –
1) By Vaccine Type: Inactivated (Killed) Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
2) By Disease Type: Feline Panleukopenia Virus (FPV), Feline Calicivirus (FCV), Feline Herpesvirus Type 1 (FHV-1), Feline Leukemia Virus (FeLV), Rabies, Feline Immunodeficiency Virus (FIV), Other disease types
3) By Technology: Live Attenuated, Inactivated, Recombinant deoxyribonucleic acid (DNA), Subunit, Toxoi
4) By Route of Administration: Injectable Vaccines, Intranasal Vaccines, Oral Vaccines
5) By End-User: Veterinary Hospitals, Veterinary Clinics, Animal Research Institutes
Subsegments:
1) By Inactivated (Killed) Vaccines: Whole Virus Vaccines, Split Virus Vaccines, Purified Antigen Vaccines
2) By Live Attenuated Vaccines: Modified Live Virus Vaccines, Temperature Sensitive Mutant Vaccines, Attenuated Viral Vector Vaccines
3) By Recombinant Vaccines: Recombinant Viral Vector Vaccines, Recombinant Subunit Vaccines, Deoxyribonucleic Acid (DNA) Based Recombinant Vaccines
Feline Vaccines Market Innovation Trends Driving Future Development
Leading companies in the feline vaccines market are concentrating on developing advanced offerings, such as recombinant vector vaccines, to boost effectiveness, enhance safety, and provide broader protection. Recombinant vector vaccines are sophisticated immunizations that utilize a harmless virus to deliver specific antigens, stimulating a strong and targeted immune response against the intended pathogen. For instance, in September 2024, MSD Animal Health, a US-based global animal health company, received USDA approval for Nobivac NXT FeLV, a feline leukemia virus vaccine leveraging its RNA-particle technology platform. This product is a next-generation, non-adjuvanted recombinant canarypox vector vaccine for feline leukemia virus (FeLV). The vaccine incorporates a patented technology designed to induce robust cell-mediated and humoral immunity, delivering enhanced protection against FeLV infection and associated diseases. It also features a low-volume, subcutaneous dose and is indicated for healthy cats 8 weeks of age or older, aiming to improve safety profiles, ease of administration, and compliance in veterinary practices.
Feline Vaccines Market Competitive Analysis Of Major Industry Participants
Major companies operating in the feline vaccines market are Merck & Co. Inc., Boehringer Ingelheim Animal Health GmbH, Zoetis Inc., Intas Pharmaceuticals Ltd., Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Virbac SA, Neogen Corporation, Laboratorios HIPRA S.A., Vetoquinol SA, Indian Immunologicals Limited, Jinyu Bio-Technology Co. Ltd., Ourofino Animal Health S.A., Biogénesis Bagó S.A., Biovet Private Limited, Hester Biosciences Limited, Biovet S.A., Durvet Inc., China Animal Husbandry Group Co. Ltd., Biopharma Laboratory, Kyoto Biken Laboratories Inc., Nisseiken Co. Ltd., Liaoning Yikang Biological Co. Ltd., Torigen Pharmaceuticals Inc., Bioveta a.s.
Access The Complete Feline Vaccines Market Report:
Feline Vaccines Market Geographic Distribution And Regional Opportunities
North America was the largest region in the feline vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the feline vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.